300078 思创医惠
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入603,8196.95%690,7661,005,9291,115,911963,143
减:营业总成本711,901-4.79%975,0091,321,0561,480,0821,342,993
    其中:营业成本539,79714.52%606,939794,314937,018787,288
               财务费用19,900-50.26%52,72881,41580,09485,159
               资产减值损失(15,832)-73.94%(114,981)(270,512)(430,612)(328,052)
公允价值变动收益(1,328)-888.80%(14,331)(54,474)(9,705)21,162
投资收益144,804-11,881.02%(1,139)(12,090)3,87236,885
    其中:对联营企业和合营企业的投资收益2,200-166.48%(4,127)(35,501)(8,681)(22,995)
营业利润(3,050)-98.92%(452,188)(716,848)(874,377)(702,922)
利润总额(3,909)-98.62%(501,431)(807,364)(874,184)(718,756)
减:所得税费用2,577-10.12%2,66268,1128,405(26,979)
净利润(6,486)-97.73%(504,093)(875,476)(882,589)(691,778)
减:非控股权益(1,724)-17.09%(2,583)(1,127)(4,640)(6,550)
股东净利润(4,762)-98.32%(501,510)(874,349)(877,948)(685,228)

市场价值指针
每股收益 (元) *0.000-100.00%-0.530-1.060-1.060-0.820
每股派息 (元) *------------
每股净资产 (元) *0.5170.02%0.5150.3701.2712.270
审计意见 #--保留意见保留意见保留意见保留意见
回页顶
备注: *未调整数据
#只提供简体内容